ACADIA Pharmaceuticals In...

NASDAQ: ACAD · Real-Time Price · USD
25.16
0.63 (2.57%)
At close: Aug 15, 2025, 1:29 PM

ACADIA Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
319.59M 188.66M 114.85M 147.44M
Short-Term Investments
436.4M 250.21M 301.98M 373.27M
Long-Term Investments
n/a 5.77M 12.97M 9.37M
Other Long-Term Assets
78.87M 5.1M 5.31M 6.61M
Receivables
104.69M 102.35M 63.08M 65.34M
Inventory
21.95M 35.82M 6.64M 7.88M
Other Current Assets
n/a n/a n/a n/a
Total Current Assets
938.32M 616.13M 507.94M 617.82M
Property-Plant & Equipment
50.79M 56.47M 61.59M 66.31M
Goodwill & Intangibles
119.78M 65.49M n/a n/a
Total Long-Term Assets
249.44M 132.83M 79.88M 82.3M
Total Assets
1.19B 748.96M 587.81M 700.12M
Account Payables
16.19M 17.54M 12.75M 6.88M
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
n/a n/a n/a n/a
Other Current Liabilities
114.28M 92.31M 49.51M 39.27M
Total Current Liabilities
394.87M 254.25M 125.63M 96.07M
Long-Term Debt
n/a n/a n/a 56.13M
Other Long-Term Liabilities
18.06M 15.15M 9.07M -49.09M
Total Long-Term Liabilities
60.09M 62.95M 61.77M 63.16M
Total Liabilities
454.96M 317.2M 187.4M 159.23M
Total Debt
51.99M 57.2M 62M 56.13M
Common Stock
16K 16K 16K 16K
Retained Earnings
-2.2B -2.43B -2.37B -2.15B
Comprehensive Income
292K 24K -975K -192K
Shareholders Equity
732.79M 431.75M 400.41M 540.89M
Total Investments
436.4M 255.98M 301.98M 373.27M